Cancer Research Meeting Calendar  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floryk, D.
Right arrow Articles by Huberman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floryk, D.
Right arrow Articles by Huberman, E.
[Cancer Research 65, 11588-11596, December 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Differentiation of Androgen-Independent Prostate Cancer PC-3 Cells Is Associated with Increased Nuclear Factor-{kappa}B Activity

Daniel Floryk and Eliezer Huberman

Gene Expression Group, Argonne National Laboratory, Argonne, Illinois

Requests for reprints: Eliezer Huberman, Gene Expression Group, Argonne National Laboratory, Building 202, 9700 South Cass Avenue, Argonne, IL 60439. Phone: 630-252-3820; Fax: 630-252-9155; E-mail: elih{at}anl.gov.com.

Recently, we have reported that inosine 5'-monophosphate dehydrogenase inhibitors, such as mycophenolic acid (MPA), induce the differentiation of PC-3 cells, which are derived from a human androgen-independent prostate cancer, into cells with a phenotype resembling maturing prostate secretory cells. Here, we describe such differentiation induced by the histone deacetylase inhibitor tributyrin. The maturation was defined by cytoplasmic vacuole production and induction of CD10, CD46, CD55, GRP78, keratin 17, and zinc-{alpha}-2-glycoprotein. To identify additional genes associated with tributyrin-induced PC-3 cell differentiation and to gain some insight into the mechanism that underlies this differentiation, we have, by means of microarray analyses, compared tributyrin-induced gene expression patterns with those of MPA, which initiates PC-3 cell differentiation by a dissimilar mode of action. We suggested that genes induced by both tributyrin and MPA would be most likely associated with differentiation rather than with the unique action of each particular inducer. Our results indicated that tributyrin or MPA induced the expression of a large number of common genes, including genes known or assumed to be NF-{kappa}B dependent. The NF-{kappa}B dependency of a group of these genes, which included the PC-3 cell differentiation marker keratin 17, was confirmed by using two common NF-{kappa}B activation inhibitors, Bay11-082 and TMB-8, and p65 subunit of NF-{kappa}B complex specific small interfering RNA. Taken together, our results implicate both NF-{kappa}B–dependent and NF-{kappa}B–independent genes in the processes leading to PC-3 cell differentiation induced by tributyrin and MPA. (Cancer Res 2005; 65(24): 11588-96)




This article has been cited by other articles:


Home page
Anticancer ResHome page
S. KOKENY, J. PAPP, G. WEBER, T. VASZKO, P. CARMONA-SAEZ, and E. OLAH
Ribavirin Acts via Multiple Pathways in Inhibition of Leukemic Cell Proliferation
Anticancer Res, June 1, 2009; 29(6): 1971 - 1980.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra
Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies
Endocr. Rev., April 1, 2008; 29(2): 234 - 252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.